Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Rhythm Pharmaceuticals (RYTM) Debt Ratio (2016 - 2025)

Historic Debt Ratio for Rhythm Pharmaceuticals (RYTM) over the last 5 years, with Q3 2025 value amounting to 0.21.

  • Rhythm Pharmaceuticals' Debt Ratio changed N/A to 0.21 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.21, marking a year-over-year change of. This contributed to the annual value of 0.28 for FY2024, which is 1224.46% down from last year.
  • As of Q3 2025, Rhythm Pharmaceuticals' Debt Ratio stood at 0.21.
  • Rhythm Pharmaceuticals' 5-year Debt Ratio high stood at 0.32 for Q4 2023, and its period low was 0.21 during Q3 2025.
  • Its 3-year average for Debt Ratio is 0.28, with a median of 0.28 in 2025.
  • Data for Rhythm Pharmaceuticals' Debt Ratio shows a peak YoY increase of 1224.46% (in 2024) and a maximum YoY decrease of 1224.46% (in 2024) over the last 5 years.
  • Rhythm Pharmaceuticals' Debt Ratio (Quarter) stood at 0.32 in 2023, then decreased by 12.24% to 0.28 in 2024, then dropped by 23.2% to 0.21 in 2025.
  • Its Debt Ratio was 0.21 in Q3 2025, compared to 0.29 in Q2 2025 and 0.28 in Q1 2025.